Michel Rigaud
Overview
Explore the profile of Michel Rigaud including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barriere G, Rigaud M, Arrat C, Colombi H, Poli E
Anticancer Res
. 2023 Feb;
43(3):1053-1064.
PMID: 36854538
Background/aim: Circulating tumor cells (CTC) are tumor cells which can be disseminated at distance of the primary tumor and form metastatic niche. Moreover, their quantity is an important parameter which...
2.
Fici P, Gallerani G, Morel A, Mercatali L, Ibrahim T, Scarpi E, et al.
Oncotarget
. 2016 Dec;
8(2):2423-2436.
PMID: 27911856
Epithelial-to-mesenchymal transition (EMT) has been shown to be associated with tumor progression and metastasis. During this process in breast cancer, a crucial role is played by alternative splicing systems. To...
3.
Barriere G, Fici P, Gallerani G, Fabbri F, Rigaud M
Clin Transl Med
. 2015 May;
4:14.
PMID: 25932287
Epithelial mesenchymal transition (EMT) is a physiological process necessary to normal embryologic development. However in genesis of pathological situations, this transition can be perverted and signaling pathways have different regulations...
4.
Barriere G, Fici P, Gallerani G, Fabbri F, Zoli W, Rigaud M
Ann Transl Med
. 2014 Dec;
2(11):109.
PMID: 25489583
Until now detection and numeration of circulating tumor cells (CTCs) were essentially used as a prognostic factor in cancer progression. To extend the role of these kinds of analysis, it...
5.
Barriere G, Rigaud M
Ann Transl Med
. 2014 Oct;
1(2):19.
PMID: 25332963
In the Science issue of first February 2013 Yu M et al. characterized epithelial and mesenchymal circulating tumor cells (CTC) by RNA-in situ hybridization. In this editorial we comment their...
6.
Barriere G, Riouallon A, Renaudie J, Tartary M, Rigaud M
Anticancer Res
. 2012 Jul;
32(8):3363-9.
PMID: 22843916
Background: Breast cancer is one of the most common malignancies in women. Approximately 25% of patients with early-stage disease will develop metastatic recurrence. Two clinical trials were undertaken in order...
7.
Barriere G, Tartary M, Rigaud M
Anticancer Agents Med Chem
. 2012 Jun;
13(2):333-40.
PMID: 22721394
Metformin is a biguanide derivative which is widely prescribed as an oral drug for diabetes mellitus type 2. This old molecule has recently received a new attention because of its...
8.
Barriere G, Tartary M, Rigaud M
ISRN Oncol
. 2012 May;
2012:382010.
PMID: 22577580
Many research groups reported on the relation between circulating tumor cells (CTCs) in peripheral blood and worse prognosis for metastatic cancer patients. These results are based on CTCs counting and...
9.
Barriere G, Riouallon A, Renaudie J, Tartary M, Rigaud M
BMC Cancer
. 2012 Mar;
12:114.
PMID: 22443102
Background: Epithelial mesenchymal transition (EMT) is a crucial event likely involved in dissemination of epithelial cancer cells. This process enables them to acquire migratory/invasive properties, contributing to tumor and metastatic...
10.
Aubry K, Shao Z, Monteil J, Paraf F, Bessede J, Rigaud M
Mol Imaging Biol
. 2008 Nov;
11(2):88-93.
PMID: 19034583
Purpose: The aim of this study was to demonstrate the ability to use human clinical positron emission tomography/computed tomography (PET/CT) to detect and investigate head and neck cancers chemically induced...